FDA Approved: AMBRISENTAN — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved a supplemental application for ambrisentan from Apotex Corp., resulting in an approved update to its labeling under the existing indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Ambrisentan (Ambrisentan)

Snippet

SUPPL AP for AMBRISENTAN (AMBRISENTAN)